United Therapeutics | UTHR - Le Revenu D'Intérêts





Le Revenu D'Intérêts Changement Date
Amarin USD 3.37M 3.37M 2024-12
Baxter International USD 10M 4M 2025-09
Bayer EUR 130M 38M 2025-09
BioCryst Pharmaceuticals USD -0.13 3.59M 2024-12
Biogen USD 31.6M 700K 2025-09
BioMarin Pharmaceutical USD 17.85M 973K 2025-09
Esperion Therapeutics USD -0.15 0.18 2024-09
Gilead Sciences USD 88M 15M 2025-09
GlaxoSmithKline GBP 26M 24M 2025-09
Insmed USD 765K 55K 2024-09
Ionis Pharmaceuticals USD -0.66 0.29 2024-12
J&J USD 2.12 0.17 2025-09
Moderna USD 73M 8M 2025-09
Pfizer USD 0.62 156M 2025-09
Regeneron Pharmaceuticals USD 175.1M 300K 2025-09
Sarepta Therapeutics USD 8.38M 1.24M 2025-09
United Therapeutics USD 46.4M 4.9M 2025-09
Vertex Pharmaceuticals USD 125.7M 3.3M 2025-09